Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685451 · ClinicalTrials.gov registry record · Phase 1
Cognitive Therapy for PTSD in Addiction Treatment
A Phase 1 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 49
- Enrollment target
- 3
- Study locations
NCT00685451: Completed Phase 1 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00685451 is a Phase 1 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 49 participants, below the 155-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (68% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00685451, a Phase 1 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 49 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this phase of the study is to assess the feasibility of a cognitive behavioral therapy for post-traumatic stress disorder (PTSD) in persons receiving outpatient services at an addiction treatment program. The next phase of the study will be a more rigorous investigation of the efficacy of the PTSD therapy within addiction treatment settings.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
Study Locations (3)
New Hampshire
- Fresh Start at Concord Hospital - Concord
- Farnum Center - Manchester
Vermont
- Quitting Time - Wilder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-11 |
| Phase | Phase 1 |
What the finished NCT00685451 record still lists
NCT00685451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 155-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (68% lower).
The record links to 2 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT00685451 reports a single indexed study location in New Hampshire, Vermont.
Frequently Asked Questions
What is clinical trial NCT00685451 about?
NCT00685451 is a clinical study titled "Cognitive Therapy for PTSD in Addiction Treatment". The purpose of this phase of the study is to assess the feasibility of a cognitive behavioral therapy for post-traumatic stress disorder (PTSD) in persons receiving outpatient services at an addiction treatment program. The next phase of the study will be a more rigorous investigation of the efficac...
What is the current status of trial NCT00685451?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2004-11. Estimated completion is 2006-11.
What conditions does trial NCT00685451 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Substance-Related Disorders.
What interventions are being tested in trial NCT00685451?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00685451?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00685451 being conducted?
This trial has 3 study locations across New Hampshire, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00685451's enrollment target sits among peer trials
49 50th of 66 higher than 17 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
COMPLETED · Phase 1
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Overcontrol and Suicide in PTSD
RECRUITING
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia